Current Opinion in Investigational Drugs | Most viewed articles of all time

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries jobs about my BioMed Central home journals A-Z subject areas advanced search authors reviewers libraries jobs about my BioMed Central

Quick Search

	Current Opinion in Investigational Drugs
	BioMed Central
	PubMed Central
	PubMed

Jump to article


vol.	page no.

Current Opinion in Investigational Drugs

Most viewed

Current Opinion in Investigational Drugs: Most viewed articles of all time

Figures given indicate the abstract, full text and PDF accesses on BioMed Central for each article, for all time. All research articles are also available via the PubMed Central archive, so the total number of accesses to each article is significantly higher. Lists of most-viewed articles over the last 30 days and most-viewed articles in the past year are also available.

all time most-viewed articles from all BioMed Central Journals

1. Accesses 1384	Review Review of the clinical experience with 5-azacytidine and 5-aza-2'-deoxycytidine in solid tumors. A Aparicio, JS Weber Current Opinion in Investigational Drugs 2002, 3:627-633 (30April2002) [PDF] [PubMed] [Related articles]
2. Accesses 757	Review MK-431 (Merck) CF Deacon Current Opinion in Investigational Drugs 2005, 6:419-426 (4April2005) [PDF] [PubMed] [Related articles]
3. Accesses 595	Review Rimonabant (Sanofi-Synthelabo). JR Fernandez, DB Allison Current Opinion in Investigational Drugs 2004, 5:430-435 (7April2004) [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
4. Accesses 577	Feature review Obesity drugs in clinical development JCG Halford Current Opinion in Investigational Drugs 2006, 7:312-318 (27March2006) [PDF] [PubMed] [Related articles]
5. Accesses 559	Review LAF-237 (Novartis) D Barlocco Current Opinion in Investigational Drugs 2004, 5:1094-1100 (6October2004) [PDF] [PubMed] [Related articles]
6. Accesses 499	Review Sodium-glucose cotransporter inhibitors for diabetes M Isaji Current Opinion in Investigational Drugs 2007, 8:285-292 (28March2007) [PDF] [PubMed] [Related articles]
7. Accesses 486	Review Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome HJ Harwood Current Opinion in Investigational Drugs 2004, 5:283-289 (11March2004) [PDF] [PubMed] [Related articles]
8. Accesses 468	Review Cannabinoid receptor antagonists and obesity. SC Black Current Opinion in Investigational Drugs 2004, 5:389-394 (7April2004) [PDF] [PubMed] [Related articles]
9. Accesses 447	Review Altering the Th1/Th2 balance as a therapeutic strategy in asthmatic diseases. A Ray, L Cohn Current Opinion in Investigational Drugs 2000, 1:442-448 (4December2000) [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
10. Accesses 433	Review SU-11248 (SUGEN). KM Sakamoto Current Opinion in Investigational Drugs 2004, 5:1329-1339 (29November2004) [PDF] [PubMed] [Related articles]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us